Nephrin and endothelial injury

Pavenstadt, 2003, Cell biology of the glomerular podocyte, Physiol Rev, 83, 253, 10.1152/physrev.00020.2002

Kestila, 1998, Positionally cloned gene for a novel glomerular protein–nephrin–is mutated in congenital nephrotic syndrome, Mol Cell, 1, 575, 10.1016/S1097-2765(00)80057-X

Ruotsalainen, 1999, Nephrin is specifically located at the slit diaphragm of glomerular podocytes, Proc Natl Acad Sci U S A, 96, 7962, 10.1073/pnas.96.14.7962

Rodewald, 1974, Porous substructure of the glomerular slit diaphragm in the rat and mouse, J Cell Biol, 60, 423, 10.1083/jcb.60.2.423

Obeidova, 2006, Genetic basis of nephrotic syndrome: review, Prague Med Rep, 107, 5

Jones, 2006, Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes, Nature, 440, 818, 10.1038/nature04662

Palmen, 2001, Nephrin is expressed in the pancreatic beta cells, Diabetologia, 44, 1274, 10.1007/s001250100641

Zanone, 2008, From endothelial to Beta cells: insights into pancreatic islet microendothelium, Curr Diabetes Rev, 4, 1, 10.2174/157339908783502415

Camussi, 1993, Effect of cytokines on the cytoskeleton of resident glomerular cells, Kidney Int Suppl, 39, S32

Garg, 2007, Slit diaphragm junctional complex and regulation of the cytoskeleton, Nephron Exp Nephrol, 106, e67, 10.1159/000101795

Ichimura, 2007, Actin filament organization of foot processes in vertebrate glomerular podocytes, Cell Tissue Res, 329, 541, 10.1007/s00441-007-0440-4

Schlondorff, 2008, Nephrin AKTs on actin: The slit diaphragm-actin cytoskeleton signaling network expands, Kidney Int, 73, 524, 10.1038/sj.ki.5002741

Doublier, 2001, Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome, Am J Pathol, 158, 1723, 10.1016/S0002-9440(10)64128-4

Zhu, 2008, Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes, Kidney Int, 73, 556, 10.1038/sj.ki.5002691

Foster, 2005, Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes, Am J Physiol Renal Physiol, 288, F48, 10.1152/ajprenal.00146.2004

Tapia, 2008, Semaphorin3a disrupts podocyte foot processes causing acute proteinuria, Kidney Int, 73, 733, 10.1038/sj.ki.5002726

Guan, 2006, Autocrine VEGF: a system in podocytes regulates podocin and its interaction with CD2AP, Am J Physiol Renal Physiol, 291, F422, 10.1152/ajprenal.00448.2005

Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, 111, 649, 10.1172/JCI17189

Levine, 2004, Circulating angiogenic factors and the risk of preeclampsia, N Engl J Med, 350, 672, 10.1056/NEJMoa031884

Sugimoto, 2003, Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria, J Biol Chem, 278, 12605, 10.1074/jbc.C300012200

Collino, 2008, Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells, Am J Physiol Renal Physiol, 294, F1185, 10.1152/ajprenal.00442.2007

Doublier, 2003, Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II, Diabetes, 52, 1023, 10.2337/diabetes.52.4.1023

Liebau, 2006, Functional expression of the renin-angiotensin system in human podocytes, Am J Physiol Renal Physiol, 290, F710, 10.1152/ajprenal.00475.2004

Isermann, 2007, Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis, Nat Med, 13, 1349, 10.1038/nm1667

Durvasula, 2008, Activation of a local renin angiotensin system in podocytes by glucose, Am J Physiol Renal Physiol, 294, F830, 10.1152/ajprenal.00266.2007

Ideura, 2007, Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy, Am J Physiol Renal Physiol, 293, F1214, 10.1152/ajprenal.00162.2007

Reiser, 2007, Dual effects of RAS blockade on blood pressure and podocyte function, Curr Hypertens Rep, 9, 403, 10.1007/s11906-007-0074-7

Vaziri, 2007, Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction, J Pharmacol Exp Ther, 323, 85, 10.1124/jpet.107.123638

Hoffmann, 2004, Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats, J Am Soc Nephrol, 15, 1475, 10.1097/01.ASN.0000127988.42710.A7

Sharma, 1998, Documentation of angiotensin II receptors in glomerular epithelial cells, Am J Physiol, 274, F623

Jia, 2008, Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis, Am J Nephrol, 28, 500, 10.1159/000113538

Knight, 2008, Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet, Hypertension, 51, 352, 10.1161/HYPERTENSIONAHA.107.099499

Burt, 2007, The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes, Am J Pathol, 171, 1789, 10.2353/ajpath.2007.070398

Chow, 2004, Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury, Kidney Int, 65, 116, 10.1111/j.1523-1755.2004.00367.x

Wada, 1996, Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1), FASEB J, 10, 1418, 10.1096/fasebj.10.12.8903512